“…Although, research efforts have appeared promising, vaccine field trials continue to produce inadequate results or fail entirely (de Leeuw et al, 1980;Myers and Snodgrass, 1982;Snodgrass et al, 1982;Waltner-Toews et al, 1985;Yuan et al, 1998). The inadequacy of rotavirus vaccines may be explained, in part, by the complex antigenic diversity of the group A rotaviruses (Woode et al, , 1987Zheng et al, 1989;Hardy et al, 1991;Parwani et al, 1993;, and by doubts concerning which of the two main antigens, VP4 or VP7, is the most important antigen to induce immune protection (Ward et al, 1993;. In addition, immunizing neonates with modified live rotavirus or coronavirus vaccine is difficult because of interference by colostral antibodies which contain neutralizing activity and effectively block the host's immune response (Waltner-Toews et al, 1985).…”